abstract |
An AGE production inhibitor composition which inhibits the production of an AGE, causative of diabetic complications such as cataract, nephropathy, and retinopathy, is provided. The composition comprises (a) a Maillard reaction inhibitor, e.g., a compound represented by formula (1), (2) or (3), or a pharmaceutically acceptable salt thereof, and (b) vitamin B6 or a pharmaceutically acceptable salt thereof, wherein the individual groups are as described in the specification. |